Story perspectives

Congress Considers Bill to Make Weight Loss Drugs Accessible

12/13/2025

23 2

Summary

Story summary

Bipartisan support exists for addressing obesity through weight loss drugs such as Ozempic and Tirzepatide, but accessibility remains limited due to high costs, with Ozempic at $997.58 per month.
The Treat and Reduce Obesity Act of 2023 would expand Medicare coverage for these medications, targeting low-income individuals.
Pending approval in Congress, the bill could expand coverage as obesity-related diseases such as diabetes and hypertension improve with weight management.

1 of 1

Story summary

Bipartisan support exists for addressing obesity through weight loss drugs such as Ozempic and Tirzepatide, but accessibility remains limited due to high costs, with Ozempic at $997.58 per month.
The Treat and Reduce Obesity Act of 2023 would expand Medicare coverage for these medications, targeting low-income individuals.
Pending approval in Congress, the bill could expand coverage as obesity-related diseases such as diabetes and hypertension improve with weight management.